-----Original Message-----
From: StemCells, Inc. [mailto:[log in to unmask]] 
Sent: Thursday, October 04, 2012 09:06
To: [log in to unmask]
Subject: StemCells, Inc. Announces First Transplant of Neural Stem Cells
Into Patient in Clinical Trial for Dry Age-Related Macular Degeneration

 <http://media.corporate-ir.net/media_files/IROL/86/86230/email_h.jpg> 	
StemCells, Inc. has added a news release to its Investor Relations website.

Title: StemCells, Inc. Announces First Transplant of Neural Stem Cells Into
Patient in Clinical Trial for Dry Age-Related Macular Degeneration

Date(s): 4-Oct-2012 9:01 AM

For a complete listing of our news releases, please click here
<http://investor.stemcellsinc.com/phoenix.zhtml?c=86230&p=irol-news&nyo=0> 


________________________________

If you are unable to click on the link above, please copy and paste the URL
below into a web browser
http://investor.stemcellsinc.com/phoenix.zhtml?c=86230&p=irol-news&nyo=0 
Thomson Reuters Inc. 22 Thomson Place Boston, MA 02210 	
Click Here
<http://origin-www.corporate-ir.net/ireye/unsubscribe.zhtml?t=2743&a=ir-news
>  to unsubscribe from this JoinMail list. 	

	

________________________________

-----------------------

To change your mail settings or leave the C-PALSY list, go here:

http://listserv.icors.org/SCRIPTS/WA-ICORS.EXE?SUBED1=c-palsy